CLDI
Calidi Biotherapeutics, Inc.
1-for-16 reverse split, effective Jul 31, 2026.
- Ratio
- 1-for-16
- Effective date
- Jul 31, 2026
- Last day to buy
- Jul 30, 2026
- Be on record by
- Filing does not state a record date
- Fractional shares
- Rounds up
- Form
- 8-K
Prior NYSE session before the effective date. Calculated, not a filing field.
Filed Jul 31, 2026
Split Adjustment; Treatment of Fractional Shares On the Effective Date, the total number of shares of Common Stock held by each stockholder of the Company were exchanged for the number of shares of Common Stock equal to the number of issued and outstanding shares of Common Stock held by each such stockholder immediately prior to the Reverse Stock Split, divided by sixteen (16), with such resulting number of shares rounded up to the nearest whole share.
Broker reports
No approved reports yet. If your broker handled this split, send a report.